scispace - formally typeset
L

Loïc Guillevin

Researcher at University of Paris

Publications -  839
Citations -  57858

Loïc Guillevin is an academic researcher from University of Paris. The author has contributed to research in topics: Vasculitis & Granulomatosis with polyangiitis. The author has an hindex of 108, co-authored 800 publications receiving 51085 citations. Previous affiliations of Loïc Guillevin include Paris Descartes University & Pasteur Institute.

Papers
More filters

2012 Revised International Chapel Hill Consensus Conference Nomenclature of

TL;DR: In this article, the running head is assigned to one of the following candidates:Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Ferrardo F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CGM, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees
Journal ArticleDOI

Churg-Strauss Syndrome. Clinical Study and Long-Term Follow-Up of 96 Patients

TL;DR: The long-term prognosis of CSS is good and does not differ from that of polyarteritis nodosa, although most patients need low doses of oral corticosteroids for persistent asthma, even many years after clinical recovery from vasculitis.
Journal ArticleDOI

Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis

TL;DR: Plasma exchange increased the rate of renal recovery in ANCA-associated systemic vasculitis that presented with renal failure when compared with intravenous methylprednisolone, and survival and severe adverse event rates were similar in both groups.
Journal ArticleDOI

Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis

Gerald B. Appel, +98 more
TL;DR: Although most patients in both treatment groups experienced clinical improvement, the study did not meet its primary objective of showing that MMF was superior to IVC as induction treatment for lupus nephritis.